A Study of Remimazolam Tosilate for Sedation in the ICU

Clinical trial NCT06222294 · COMPLETED

Trial details

NCT number: NCT06222294
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Sedation in the ICU

Start date: 2024-03-12
Primary completion: 2024-08-13
Enrollment: 214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.